New MRI study reveals hidden neck muscle changes in ankylosing spondylitis
NCT ID NCT07148167
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used MRI to examine neck muscles in 158 people with ankylosing spondylitis (AS), a type of arthritis that affects the spine. Researchers measured muscle size, fat buildup, and spine alignment, comparing them to healthy controls. The goal was to better understand how AS affects the neck, which could help guide future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how ankylosing spondylitis affects neck muscles, potentially leading to improved monitoring or treatment approaches.
- What could go wrong
- This is a completed observational study, not a treatment trial. It only looks at MRI images, so it cannot directly improve patient outcomes or prove any new therapy works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
158 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Nov 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
For the study group: * Patients diagnosed with ankylosing spondylitis, aged 18-50. * Patients who underwent a cervical MRI between January 2020 and September 2023. Control Group Patients aged 18-50 who underwent cervical MRI between January 2020 and September 2023 due to nonspecific neck pain, who did not have an AS diagnosis and whose cervical MRI was reported as normal.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * For the study group: * Patients diagnosed with ankylosing spondylitis, aged 18-50. * Patients who underwent a cervical MRI between January 2020 and September 2023. Control Group Patients aged 18-50 who underwent cervical MRI between January 2020 and September 2023 due to nonspecific neck pain, who did not have an AS diagnosis and whose cervical MRI was reported as normal. Exclusion Criteria: * Patients over 50 years of age * History of spine surgery; * Presence of pain, numbness, and weakness in the upper extremities * History of cervical injury or neck injury * Presence of tuberculosis, tumor, fracture, infection, instability, cervical myelopathy, cervical disc herniation (protrusion, extrusion) (will be considered cervical bulging) * Presence of cervical radiculopathy * Those with a detectable pathological spinal condition related to neck pain, including spinal deformity; inflammatory or rheumatic diseases other than AS, malignancies, or neurological diseases * A cognitive or psychological disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kayseri City Hospital
Kayseri, Kocasinan, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can taekwondo kicks ease ankylosing spondylitis?
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a simple protein test unlock the secrets of joint disease?
- Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
- New antibody aims to calm ankylosing spondylitis